American Well Net Income 2019-2024 | AMWL
American Well net income from 2019 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| American Well Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-208 |
| 2023 | $-675 |
| 2022 | $-270 |
| 2021 | $-176 |
| 2020 | $-224 |
| 2019 | $-87 |
| 2018 | $-53 |
| American Well Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-43 |
| 2024-09-30 | $-43 |
| 2024-06-30 | $-50 |
| 2024-03-31 | $-72 |
| 2023-12-31 | $-49 |
| 2023-09-30 | $-136 |
| 2023-06-30 | $-92 |
| 2023-03-31 | $-398 |
| 2022-12-31 | $-61 |
| 2022-09-30 | $-70 |
| 2022-06-30 | $-69 |
| 2022-03-31 | $-70 |
| 2021-12-31 | $-48 |
| 2021-09-30 | $-51 |
| 2021-06-30 | $-38 |
| 2021-03-31 | $-39 |
| 2020-12-31 | $-50 |
| 2020-09-30 | $-63 |
| 2020-06-30 | $-87 |
| 2020-03-31 | $-24 |
| 2019-12-31 | |
| 2019-09-30 | $-24 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.123B | $0.254B |
| American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.685B | 52.05 |
| Tempus AI (TEM) | United States | $8.308B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.565B | 105.54 |
| Inspire Medical Systems (INSP) | United States | $4.740B | 92.07 |
| IRhythm Technologies (IRTC) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.706B | 204.09 |
| Enovis (ENOV) | United States | $2.177B | 13.50 |
| Clover Health Investments (CLOV) | United States | $1.834B | 0.00 |
| Omnicell (OMCL) | United States | $1.635B | 35.31 |
| Azenta (AZTA) | United States | $1.583B | 73.70 |
| Phreesia (PHR) | United States | $1.502B | 0.00 |
| Schrodinger (SDGR) | United States | $1.442B | 0.00 |
| 10x Genomics (TXG) | United States | $1.068B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.554B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.522B | 0.00 |
| Veradigm (MDRX) | United States | $0.469B | 0.00 |
| Talkspace (TALK) | United States | $0.431B | 256.00 |
| TruBridge (TBRG) | United States | $0.411B | 0.00 |
| Standard BioTools (LAB) | United States | $0.409B | 0.00 |
| Claritev (CTEV) | United States | $0.334B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.238B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.221B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| CareCloud (CCLD) | United States | $0.059B | 2.53 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |